Skip to content

Clinical trials

Breast Diseases trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Diseases Country / region: Canada Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20101
20113
20151
20192
20213
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status4
Active, not recruiting3
Completed3
Recruiting2
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca3
Women's College Hospital2
Hoffmann-La Roche1
McGill University Health Centre/Research Institute of the McGill University Health Centre1
Medifocus, Inc.1
Nova Scotia Health Authority1
Novartis Pharmaceuticals1
University Health Network, Toronto1
University of British Columbia1
Western University, Canada1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Diseases13
Breast Neoplasms8
Neoplasms6
Neoplasms by Site6
Neoplasm Metastasis3
Skin Diseases3
Agnosia1
Genetic Predisposition to Disease1
Hyperthermia1
Multiple Endocrine Neoplasia Type 11

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.